Computerized cyclic voltammetric detection after HPLC of the antineoplastic agents etoposide, teniposide, adriamycin and its metabolite adriamycinol in urine samples

A computerized electrochemical detection system for application after HPLC, provided with a cyclic voltammetric oxidative and reductive module, is described for the on-line qualitative determination of electroactive antineoplastic agents and metabolites in urine samples, collected from cancer patients, following intravenous administration

Can yield gap analysis be used to inform R & D prioritisation?

The phrase “biggest bang for a buck” is associated with the policy making question that governments and development agencies face: “Where and which crops should receive highest priority for improving local and global food supply?”. A first step of prioritisation is to identify region x crop combinations for which high impact can be anticipated. We developed a new method for this prioritisation exercise and applied it to data from the Global Yield Gap and Water Productivity Atlas (GYGA). Our prioritisation distinguishes between two policy objectives (humanitarian and economic) and builds upon the relative yield gap and climate risk. Results of the prioritisation are presented and visualised in Google Earth

The Disk and Dark Halo Mass of the Barred Galaxy NGC 4123. II. Fluid-Dynamical Models

We report a dynamical determination of the separate contributions of disk and dark halo masses to the rotation curve of a spiral galaxy. We use fluid-dynamical models of gas flow in the barred galaxy NGC 4123 to constrain the dynamical properties of the galaxy: disk M/L, bar pattern speed, and the central density and scale radius of the dark halo. We derive a realistic barred potential directly from the light distribution. For each model we assume a value of the stellar M/L and a bar pattern speed Omega_p and add a dark halo to fit the rotation curve. We then compute the gas flow velocities with a 2-D gas dynamical code, and compare the model flow patterns to a 2-D velocity field derived from Fabry-Perot observations. The strong shocks and non-circular motions in the observed gas flow require a high stellar M/L and a fast-rotating bar. Models with I-band disk M/L of 2.0 -- 2.5 h_75, or 80 -- 100% of the maximum disk value, are highly favored. The corotation radius of the bar must be <= 1.5 times the bar semi-major axis. These results contradict some recent claimed ``universal'' galaxy disk/halo relations, since NGC 4123 is of modest size (rotation curve maximum 145 km/sec, and V_flat = 130 km/sec) yet is quite disk-dominated. The dark halo of NGC 4123 is less concentrated than favored by current models of dark halos based on cosmological simulations. Since some 30% of bright disk galaxies are strongly barred and have dust lanes indicating shock morphology similar to that of NGC 4123, it is likely that they also have high stellar M/L and low density halos. We suggest that luminous matter dominates inside the optical radius R_25 of high surface brightness disk galaxies.Comment: accepted by ApJ, 20 pages, 11 figures (2 color), uses emulateapj.sty, onecolfloat.st

On Albanese torsors and the elementary obstruction

We show that the elementary obstruction to the existence of 0-cycles of degree 1 on an arbitrary variety X (over an arbitrary field) can be expressed in terms of the Albanese 1-motives associated with dense open subsets of X. Arithmetic applications are given

Thermal unfolding and refolding of a lytic polysaccharide monooxygenase from <em>Thermoascus</em> aurantiacus

Lytic polysaccharide monooxygenases (LPMOs) are copper-containing enzymes which promote the degradation of recalcitrant polysaccharides like cellulose or chitin. Here, we have investigated the thermostability of an LPMO from Thermoascus aurantiacus (TaLPMO9A). TaLPMO9A was found to retain most of its initial activity after incubating at 100 °C while its apparent melting temperature (Tm) is 69 °C at neutral pH. Interestingly, our studies show that holoTaLPMO9A, apoTaLPMO9A and deglycosylated TaLPMO9A can fold back to their original conformation upon lowering the temperature. In the presence of β-mercaptoethanol the protein does not refold. Activity of TaLPMO9A and refolded TaLPMO9A was studied by an Amplex® Red assay as well as by TaLPMO9A catalysed oxidation of phosphoric acid swollen cellulose (PASC). These studies confirm the functional regain of TaLPMO9A activity upon going through one cycle of unfolding and refolding. The thermal unfolding and refolding of TaLPMO9A was measured spectroscopically. Utilizing the two-state model, detailed thermodynamic parameters were obtained for holoTaLPMO. Furthermore, we have investigated the kinetics of TaLPMO9A unfolding and refolding. Our results have implications in understanding LPMO stability, which is crucial for the efficient application of LPMOs as biocatalysts during biomass degradation

The dark matter halo shape of edge-on disk galaxies - I. HI observations

This is the first paper of a series in which we will attempt to put constraints on the flattening of dark halos in disk galaxies. We observe for this purpose the HI in edge-on galaxies, where it is in principle possible to measure the force field in the halo vertically and radially from gas layer flaring and rotation curve decomposition respectively. In this paper, we define a sample of 8 HI-rich late-type galaxies suitable for this purpose and present the HI observations.Comment: Accepted for publication by Astronomy & Astrophysics. For a higher resolution version see http://www.astro.rug.nl/~vdkruit/jea3/homepage/12565.pd

高信頼度高能率映像配信サービス実現のためのコンテンツハンドリング技術に関する研究

博士（工学）神戸大

The effects of new life-prolonging drugs for metastatic castration-resistant prostate cancer (mCRPC) patients in a real-world population

Item does not contain fulltextBACKGROUND: In 2004 docetaxel was the first life-prolonging drug (LPD) registered for metastatic castration-resistant prostate cancer (mCRPC) patients. Between 2011 and 2014 new LPDs for mCRPC (cabazitaxel, abiraterone, enzalutamide, and radium-223) were introduced in the Netherlands. The objective of this study is to assess the impact of the introduction of new LPDs on treatment patterns and overall survival (OS) over time. PATIENTS AND METHODS: CRPC patients diagnosed in the years 2010-2016 in the observational, retrospective CAPRI registry (20 hospitals) were included and followed up to 2018. Two subgroups were analyzed: treatment-naïve patients (subgroup 1, n = 3600) and post-docetaxel patients (subgroup 2, n = 1355). RESULTS: In both subgroups, the use of any LPD increased: from 57% (2010-2011) to 69% (2014-2015) in subgroup 1 and from 65% (2011-2012) to 79% (2015-2016) in subgroup 2. Chemotherapy as first mCRPC-treatment (i.e., docetaxel) and first post-docetaxel treatment (i.e., cabazitaxel or docetaxel rechallenge) decreased (46-29% and 20-9% in subgroup 1 and 2, respectively), while the use of androgen-receptor targeting treatments (ART) increased from 11% to 39% and 46% to 64% in subgroup 1 and 2, respectively. In subgroup 1, median OS (mOS) from diagnosis CRPC increased from 28.5 months to 31.0 months (p = 0.196). In subgroup 2, mOS from progression on docetaxel increased from 7.9 months to 12.5 months (p < 0.001). After multiple imputations of missing values, in multivariable cox-regression analysis with known prognostic parameters, the treatment period was independent significant for OS in subgroup 1 (2014-2015 vs. 2010-2011 with HR 0.749, p < 0.001) and subgroup 2 (2015-2016 vs. 2011-2012 with HR 0.811, p = 0.037). CONCLUSION: Since 2010, a larger proportion of mCRPC patients was treated with LPDs, which was related to an increased mOS